Harvard Bioscience (HBIO) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Harvard Bioscience (HBIO) over the last 12 years, with Q1 2021 value amounting to $10.7 million.
- Harvard Bioscience's Treasury Shares changed 0.0% to $10.7 million in Q1 2021 from the same period last year, while for Mar 2021 it was $10.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.7 million for FY2020, which is 0.0% changed from last year.
- As of Q3 2025, Harvard Bioscience's Treasury Shares stood at $1.7 million, which was down 975.98% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Harvard Bioscience's Treasury Shares registered a high of $7.7 million during Q1 2021, and its lowest value of $860155.0 during Q4 2021.
- For the 5-year period, Harvard Bioscience's Treasury Shares averaged around $1.9 million, with its median value being $1.6 million (2022).
- The largest annual percentage gain for Harvard Bioscience's Treasury Shares in the last 5 years was 0.0% (2017), contrasted with its biggest fall of 0.0% (2017).
- Quarter analysis of 5 years shows Harvard Bioscience's Treasury Shares stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
- Its Treasury Shares stands at $10.7 million for Q1 2021, versus $10.7 million for Q4 2020 and $10.7 million for Q3 2020.